Mr. Speaker, the member may have been watching the news lately to hear about how citizens of the United States are crossing our borders because our drug prices are significantly lower than they are in the United States.
He may think that the Patented Medicine Prices Review Board in fact should have credit for the fact that Canadian patented medicine prices are lower than in the United States and should be applauding the government for that.
As to the appeal, we will take the case under consideration and we will determine at the appropriate time what remedies we should seek.